Advertisement
Person › Details
Clive R. Wood (Boehringer Ingelheim (Group))
Wood, Clive R. (Boehringer 201403– SVP Discovery Research before Bayer HealthCare + Dyax)
Organisation | Boehringer Ingelheim (Group) | |
Former/major organisation | Bayer HealthCare (Group) | |
Group | Bayer (Group) | |
Product | drug discovery | |
Product 2 | biopharmaceutical | |
Record changed: 2023-10-04 |
Advertisement
More documents for Clive R. Wood
- [1] Boehringer Ingelheim. (10/19/21). "Press Release: Boehringer Ingelheim and Partners to Accelerate Development of First-In-Class Gene Therapy for Patients with Cystic Fibrosis". Paris....
- [2] PureTech Health plc. (4/17/19). "Press Release: PureTech Health Announces Collaboration with Boehringer Ingelheim to Advance Immuno-oncology Product Candidates Using Its Lymphatic Targeting Platform". Boston, MA....
- [3] Boehringer Ingelheim. (8/6/18). "Press Release: Boehringer Ingelheim, the UK Cystic Fibrosis Gene Therapy Consortium, Imperial Innovations and Oxford BioMedica Announce New Partnership to Develop First-In-Class Gene Therapy for Cystic Fibrosis". Ingelhei...
- [4] Boehringer Ingelheim. (11/8/17). "Press Release: Boehringer Ingelheim and MiNA Therapeutics to Develop Novel Treatment Approaches for Fibrotic Liver Diseases". Ingelheim & London....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top